Publications by authors named "Lionel Mignion"

16Publications

Obesity and triple-negative-breast-cancer: Is apelin a new key target?

J Cell Mol Med 2020 Jul 17. Epub 2020 Jul 17.

Metabolism & Nutrition Research Group, Louvain Drug Research Institute, WELBIO (Walloon Excellence in Life sciences and BIOtechnology), UCLouvain, Université catholique de Louvain, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcmm.15639DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520321PMC
July 2020

Metabolic imaging using hyperpolarized C-pyruvate to assess sensitivity to the B-Raf inhibitor vemurafenib in melanoma cells and xenografts.

J Cell Mol Med 2020 01 13;24(2):1934-1944. Epub 2019 Dec 13.

Biomedical Magnetic Resonance (REMA) Group, Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCLouvain), Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcmm.14890DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991684PMC
January 2020

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas.

Oncotarget 2018 Mar 30;9(24):16832-16846. Epub 2018 Mar 30.

Université Catholique de Louvain, Louvain Drug Research Institute, Biomedical Magnetic Resonance Group, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.24709DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908289PMC
March 2018

Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects.

Nat Commun 2018 03 23;9(1):1208. Epub 2018 Mar 23.

Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, 53 Avenue Mounier B1.53.09, Brussels, B-1200, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-03525-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865202PMC
March 2018

Biomarkers of tumour redox status in response to modulations of glutathione and thioredoxin antioxidant pathways.

Free Radic Res 2018 Feb 31;52(2):256-266. Epub 2018 Jan 31.

a Louvain Drug Research Institute, Biomedical Magnetic Resonance Group, Université Catholique de Louvain (UCL) , Brussels , Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10715762.2018.1427236DOI Listing
February 2018

DW-MRI and (18) F-FLT PET for early assessment of response to radiation therapy associated with hypoxia-driven interventions. Preclinical studies using manipulation of oxygenation and/or dose escalation.

Contrast Media Mol Imaging 2016 Mar-Apr;11(2):115-21. Epub 2015 Oct 7.

Louvain Drug Research Institute, Biomedical Magnetic Resonance Research Group, Université catholique de Louvain, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cmmi.1670DOI Listing
December 2016

Non-invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism.

Int J Cancer 2016 Apr 9;138(8):2043-9. Epub 2015 Dec 9.

Biomedical Magnetic Resonance Group, Louvain Drug Research Institute, Université Catholique De Louvain (UCL), Avenue Mounier, 73 Box B1.73.08, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29932DOI Listing
April 2016

Monitoring chemotherapeutic response by hyperpolarized 13C-fumarate MRS and diffusion MRI.

Cancer Res 2014 Feb 27;74(3):686-94. Epub 2013 Nov 27.

Authors' Affiliations: Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium; and Department of Cancer Imaging and Metabolism, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-1914DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461058PMC
February 2014

Application of MOBILE (mapping of oxygen by imaging lipids relaxation enhancement) to study variations in tumor oxygenation.

Adv Exp Med Biol 2013 ;789:281-288

Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Av.Mounier 73.40, Brussels, 1200, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4614-7411-1_38DOI Listing
May 2014

Multimodal imaging of tumor response to sorafenib combined with radiation therapy: comparison between diffusion-weighted MRI, choline spectroscopy and 18F-FLT PET imaging.

Contrast Media Mol Imaging 2013 May-Jun;8(3):274-80

Biomedical Magnetic Resonance Group, Louvain Drug Research Institute, Université Catholique de Louvain, Belgium, Avenue Mounier 73, B-1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cmmi.1525DOI Listing
November 2013

Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry.

Radiother Oncol 2012 Oct 6;105(1):29-35. Epub 2012 Jun 6.

Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2012.04.011DOI Listing
October 2012

Hexafluorobenzene in comparison with perfluoro-15-crown-5-ether for repeated monitoring of oxygenation using 19F MRI in a mouse model.

Magn Reson Med 2013 Jan 22;69(1):248-54. Epub 2012 Mar 22.

Biomedical Magnetic Resonance Group, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mrm.24245DOI Listing
January 2013